Medivir licenses Respiratory Syncytial Virus drug program from Boehringer Ingelheim – WSJ.com

August 5, 2014 11:28 am

http://online.wsj.com/article/PR-CO-20140804-901143.html

Leave a Reply

Your email address will not be published. Required fields are marked *


*

Get in touch

Give us a call, or drop us an email. We'd love to hear from you!

Get in touch now